SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-21-032036
Filing Date
2021-12-20
Accepted
2021-12-20 16:15:22
Documents
1
Period of Report
2021-12-20

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4614
  Complete submission text file 0001493152-21-032036.txt   5977
Mailing Address 10573 W. PICO BLVD. #58 LOS ANGELES CA 90064
Business Address 11400 WEST OLYMPIC BLVD. SUITE 200 LOS ANGELES CA 90064 (888) 958-1084
Immix Biopharma, Inc. (Issuer) CIK: 0001873835 (see all company filings)

IRS No.: 454869378 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 11400 WEST OLYMPIC BLVD., SUITE 200 LOS ANGELES CA 90064
Business Address
Torchilin Vladimir P (Reporting) CIK: 0001889563 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41159 | Film No.: 211505421